Home About us Editorial board Ahead of print Browse Articles Search Submit article Instructions Subscribe Contacts Login 
  • Users Online: 79
  • Home
  • Print this page
  • Email this page

    Article Cited by others

ORIGINAL ARTICLE

Plasma concentration, genetic variation, and gene expression levels of matrix metalloproteinase 9 in Iranian patients with coronary artery disease

Mahmoodi Khalil, Kamali Koorosh, Karami Elham, Soltanpour Mohammad Soleiman

Year : 2017| Volume: 22| Issue : 1 | Page no: 8-8

   This article has been cited by
 
1 The Association Between Extracellular Matrix Metalloproteinase Inducer Polymorphisms and Coronary Heart Disease: A Potential Way to Predict Disease
Yingzheng Weng,Tingting Chen,Jianfei Ren,Difan Lu,Xiaowei Liu,Senna Lin,Chenkai Xu,Jiangjie Lou,Xiaofeng Chen,Lijiang Tang
DNA and Cell Biology. 2020; 39(2): 244
[Pubmed]  [Google Scholar] [DOI]
2 Plasma MMP-9 and TIMP-1 levels on ICU admission are associated with 30-day survival
Galateja Jordakieva,Roswitha M. Budge-Wolfram,Alexandra C. Budinsky,Mariam Nikfardjam,Georg Delle-Karth,Angelika Girard,Jasminka Godnic-Cvar,Richard Crevenna,Gottfried Heinz
Wiener klinische Wochenschrift. 2020;
[Pubmed]  [Google Scholar] [DOI]
3 Network Pharmacology-Based Prediction and Verification of the Targets and Mechanism for Panax Notoginseng Saponins against Coronary Heart Disease
Yan Dong,Lian Duan,Heng-wen Chen,Yong-mei Liu,Yun Zhang,Jie Wang
Evidence-Based Complementary and Alternative Medicine. 2019; 2019: 1
[Pubmed]  [Google Scholar] [DOI]
4 The role of matrix metalloproteinases and polymorphisms of their genes in the development of coronary heart disease
O. Pogorielova,V. Garbuzova,L. Prystupa,A. Fadeeva
Fiziolohichnyi zhurnal. 2018; 64(3): 79
[Pubmed]  [Google Scholar] [DOI]

 

Read this article